Maat Pharma SA (MAAT) — Financial Flexibility Index
Maat Pharma SA (MAAT) has a Financial Flexibility Index of -0.37x as of June 2025. Free cash flow of €-15.17 Million (operating CF €-15.37 Million minus capex €202.00K) represents 0% of total liabilities (€40.58 Million). Also explore MAAT net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Maat Pharma SA Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Maat Pharma SA across 8 annual periods. Check Maat Pharma SA (MAAT) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Maat Pharma SA (2017–2024)
Year-by-year free cash flow to debt coverage for Maat Pharma SA. For the full company profile including market capitalisation, see Maat Pharma SA market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.76x | €-21.29 Million | €-22.04 Million | €28.16 Million | ▲ +3.4% |
| 2023 | -0.78x | €-17.58 Million | €-18.67 Million | €22.46 Million | ▼ -17.4% |
| 2022 | -0.67x | €-11.94 Million | €-12.61 Million | €17.91 Million | ▲ +17.1% |
| 2021 | -0.80x | €-7.69 Million | €-7.93 Million | €9.56 Million | ▼ -22.0% |
| 2020 | -0.66x | €-5.50 Million | €-5.81 Million | €8.34 Million | ▼ -71.7% |
| 2019 | -0.38x | €-4.89 Million | €-5.02 Million | €12.73 Million | ▲ +50.5% |
| 2018 | -0.78x | €-3.58 Million | €-3.87 Million | €4.62 Million | ▲ +13.5% |
| 2017 | -0.90x | €-3.58 Million | €-3.87 Million | €3.99 Million | — |